Key result
Patients with hypertrophic cardiomyopathy had greater anterior mitral leaflet lengths compared to normal controls, independent of left ventricular hypertrophy.
Why the study?
Are mitral valve leaflet lengths increased in patients with hypertrophic cardiomyopathy compared to normal controls when measured by CMR?
Cross-Sectional (n=294)
Yes
Are mitral valve leaflet lengths increased in patients with hypertrophic cardiomyopathy compared to normal controls when measured by CMR?
CMR demonstrates that mitral valve leaflets are significantly elongated in HCM patients independent of LV hypertrophy magnitude, suggesting it is a primary phenotypic expression of the disease.
Answers are grounded in this paper and cite their sources.
Mitral leaflet measurement should not yet alter HCM management; leaves open its role as primary phenotype and impact on obstruction.
Hypertrophic cardiomyopathy (HCM) is a genetic heart disease characterized by left ventricular (LV) hypertrophy due to mutations in 11 genes encoding proteins of the sarcomere. Whether a primary abnormality of the mitral valve is part of this disease process is unresolved.
No takes yet. Share an insight, caveat, or question.
Maron et al. (2010) conducted a cross-sectional in Hypertrophic cardiomyopathy (n=294). Hypertrophic cardiomyopathy vs. Normal controls was evaluated on Anterior mitral leaflet (AML) length (p=<0.001). Patients with hypertrophic cardiomyopathy had greater anterior mitral leaflet lengths compared to normal controls, independent of left ventricular hypertrophy.
Synapse has enriched 10 related papers. Consider them for comparative context: